Skip to main content
All lobbying clients

ASSOCIATION FOR CLINICAL ONCOLOGY

Lobbying client · Virginia · filed 2025 to 2026

Professional organization for physicians and oncology professionals.

$2,390,000 Reported spend
14 Filings counted
1 Outside firm hired
54 Bills named

Spend is reported income plus in-house expenses across 14 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings top 30 of 54
  • H.R. 2120
    ROCR Value Based Program Act
    7 filings
  • H.R. 2484
    Seniors’ Access to Critical Medications Act of 2025
    7 filings
  • H.R. 3514
    Improving Seniors’ Timely Access to Care Act of 2025
    7 filings
  • H.R. 786
    Preserving Patient Access to Accountable Care Act
    7 filings
  • S. 1261
    CONNECT for Health Act of 2025
    7 filings
  • S. 1816
    Improving Seniors’ Timely Access to Care Act of 2025
    7 filings
  • S. 526
    Pharmacy Benefit Manager Transparency Act of 2025
    7 filings
  • S. 705
    Innovation in Pediatric Drugs Act of 2025
    7 filings
  • S. 864
    HELP Copays Act
    7 filings
  • H.R. 2433
    Reducing Medically Unnecessary Delays in Care Act of 2025
    6 filings
  • H.R. 3521
    Clinical Trial Modernization Act
    6 filings
  • H.R. 3955
    RAPID Reserve Act
    6 filings
  • H.R. 4101
    Cancer Drug Parity Act of 2025
    6 filings
  • H.R. 4191
    MAPS Act
    6 filings
  • H.R. 4206
    CONNECT for Health Act of 2025
    6 filings
  • S. 1031
    ROCR Value Based Program Act
    6 filings
  • S. 1460
    Preserving Patient Access to Accountable Care Act
    6 filings
  • S. 1640
    Medicare Patient Access and Practice Stabilization Act of 2025
    6 filings
  • S. 1784
    MAPS Act
    6 filings
  • S. 1954
    Biosimilar Red Tape Elimination Act
    6 filings
  • S. 2062
    RAPID Reserve Act
    6 filings
  • H.R. 1262
    Mikaela Naylon Give Kids a Chance Act
    5 filings
  • H.R. 1509
    Accelerating Kids’ Access to Care Act of 2025
    5 filings
  • H.R. 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    5 filings
  • H.R. 4425
    Palliative Care and Hospice Education and Training Act
    5 filings
  • H.R. 4559
    Prompt and Fair Pay Act
    5 filings
  • H.R. 4752
    Reducing Hereditary Cancer Act
    5 filings
  • H.R. 5081
    Telehealth Modernization Act
    5 filings
  • H.R. 5509
    Safe Step Act
    5 filings
  • H.R. 929
    Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
    5 filings
 Reported by year 2 years
  • 2026 $980,000 6 filings
  • 2025 $1,410,000 8 filings
 Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 14
  • SENATE 14
 Recent filings 14 total
Q3 report
TIBER CREEK GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $70,000 income · posted Oct 20, 2026
View →
Q3 report
ASSOCIATION FOR CLINICAL ONCOLOGY
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 expenses · posted Oct 15, 2026
View →
Q2 report
TIBER CREEK GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $70,000 income · posted Jul 19, 2026
View →
Q2 report
ASSOCIATION FOR CLINICAL ONCOLOGY
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $480,000 expenses · posted Jul 16, 2026
View →
Q1 report
TIBER CREEK GROUP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $70,000 income · posted Apr 18, 2026
View →
Q1 report
ASSOCIATION FOR CLINICAL ONCOLOGY
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $210,000 expenses · posted Apr 15, 2026
View →
Q4 report
ASSOCIATION FOR CLINICAL ONCOLOGY
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $120,000 expenses · posted Jan 20, 2026
View →
Q4 report
TIBER CREEK GROUP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $70,000 income · posted Jan 17, 2026
View →
Q3 report
TIBER CREEK GROUP
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $70,000 income · posted Oct 20, 2025
View →
Q3 report
ASSOCIATION FOR CLINICAL ONCOLOGY
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $110,000 expenses · posted Oct 17, 2025
View →
Q2 report
TIBER CREEK GROUP
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $70,000 income · posted Jul 18, 2025
View →
Q2 report
ASSOCIATION FOR CLINICAL ONCOLOGY
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $650,000 expenses · posted Jul 17, 2025
View →
Q1 report
ASSOCIATION FOR CLINICAL ONCOLOGY
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $250,000 expenses · posted Apr 17, 2025
View →
Q1 report
TIBER CREEK GROUP
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $70,000 income · posted Apr 17, 2025
View →

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem